GoodRx Holdings, Inc. (GDRX) Latest Filing Signal
Cross-checked across multiple AI analysts and grounded in the latest SEC filing.
powered by: earningsVibe.ai
Question:
What is the latest filing signal for GoodRx Holdings, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest
10-K, GoodRx Holdings, Inc.'s filing signal
turned positive.
earningsVibe SuperAnalyst™ Verdict:
TURNED POSITIVE
Signal Performance — Stock Price Since Filing
30-Day Change
-4.02%
from filing date
60-Day Change
Pending
from filing date
Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT
PERPLEXITY
Continuing Positive
GEMINI
Turned Positive
CLAUDE
Turned Negative
CHATGPT
Continuing Negative
Unlock the Full Filing Analysis
See full earningsSig™ and risksSig™ analysis across 5,000+ companies
Get Started Free →No credit card required
Question:
What does GoodRx Holdings, Inc. actually do?
Answer:
GoodRx Holdings, Inc. operates as a consumer-focused digital healthcare platform in the United States, aiming to help Americans save time and money on medications. The company's core offering is a prescription price comparison tool that provides consumers with access to negotiated prices via GoodRx codes, usable at nearly every retail pharmacy nationwide. Beyond prescription savings, GoodRx has expanded its platform to include subscription programs like GoodRx Gold and RxSmartSaver+, condition-specific solutions, and a Pharma Direct offering that partners with manufacturers to integrate affordability solutions. Its value proposition extends to healthcare providers and companies by facilitating medication adherence and providing access to consumers. The company leverages proprietary technology, including a pricing engine and a continuously updated database, to deliver dynamic, geographically relevant prescription pricing.
Question:
What are GoodRx Holdings, Inc.'s revenue drivers?
Answer:
Revenue is primarily driven by prescription transactions, where GoodRx earns fees from PBMs or pharmacies for directing consumers to their negotiated prices. Additional revenue streams include subscription offerings, Pharma Direct services, and telehealth services.
Cut through noisy SEC filings to find the signal faster
Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.
Get Started Free →No credit card required